Pull to refresh
Logo
Daily Brief
Following
Why Ranks Sign Up
Zydus Lifesciences

Zydus Lifesciences

Pharmaceutical Company

Appears in 1 story

Stories

Zydus buys its way into U.S. specialty drugs

Money Moves

Acquirer; building a U.S. specialty business

Zydus, one of India's largest drugmakers, now owns a U.S. cancer-care drug. On June 16, 2026, it finished buying Assertio Holdings for $23.50 a share in cash, a deal worth about $166 million.

Updated 2 hours ago